UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

The beginning of a new therapeutic era in acute myeloid leukemia

EJHaem, 2021-11, Vol.2 (4), p.823-833

Récher, Christian

2021

Link zum Volltext

Verfügbarkeit prüfen

Hematidrosis as a manifestation of COVID‐19 containment‐induced stress

EJHaem, 2021-02, Vol.2 (1), p.25-25

Récher, Christian

2021

Link zum Volltext

Verfügbarkeit prüfen

Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites

Nature communications, 2020-08, Vol.11 (1), p.4056-4056, Article 4056

2020

Link zum Volltext

Verfügbarkeit prüfen

Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells

Nature communications, 2021-01, Vol.12 (1), p.422-15, Article 422

2021

Link zum Volltext

Verfügbarkeit prüfen

Secondary acute myeloid leukemia: time to turn the page

Haematologica (Roma), 2024-01, Vol.109 (1), p.16-18

Récher, Christian

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical Implications of Inflammation in Acute Myeloid Leukemia

Frontiers in oncology, 2021-02, Vol.11, p.623952-623952

Recher, Christian

2021

Link zum Volltext

Verfügbarkeit prüfen

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Blood, 2021-02, Vol.137 (6), p.751-762

2021

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism

Cancer discovery, 2017-07, Vol.7 (7), p.716-735

2017

Link zum Volltext

Verfügbarkeit prüfen

Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey

Haematologica (Roma), 2018-12, Vol.103 (12), p.2040-2048

2018

Link zum Volltext

Verfügbarkeit prüfen

Follow-up of patients with R/R FLT3-mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial

Blood, 2022-06, Vol.139 (23), p.3366-3375

2022

Link zum Volltext

Verfügbarkeit prüfen

Differential prognostic values of the three AKT isoforms in acute myeloid leukemia

Scientific reports, 2024-03, Vol.14 (1), p.7070-7070

2024

Link zum Volltext

Verfügbarkeit prüfen

Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients

BMC cancer, 2019-09, Vol.19 (1), p.883-883, Article 883

2019

Link zum Volltext

Verfügbarkeit prüfen

Genomic landscape of hyperleukocytic acute myeloid leukemia

Blood cancer journal (New York), 2022-01, Vol.12 (1), p.4-4, Article 4

2022

Link zum Volltext

Verfügbarkeit prüfen

The ROS/SUMO Axis Contributes to the Response of Acute Myeloid Leukemia Cells to Chemotherapeutic Drugs

Cell reports (Cambridge), 2014-06, Vol.7 (6), p.1815-1823

2014

Link zum Volltext

Verfügbarkeit prüfen

Antileukemic activity of rapamycin in acute myeloid leukemia

Blood, 2005-03, Vol.105 (6), p.2527-2534

2005

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia

Clinical cancer research, 2023-01, Vol.29 (1), p.134-142

2023

Link zum Volltext

Verfügbarkeit prüfen

Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia

European journal of haematology, 2019-02, Vol.102 (2), p.131-142

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost comparison of post-remission strategies in younger and older AML patients in France

Blood cancer journal (New York), 2023-06, Vol.13 (1), p.100-100, Article 100

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 559

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(534)
Mit Volltextzugriff
(534)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(256)
Life Sciences & Biomedicine
(246)
Humans
(209)
Hematology
(150)
Female
(120)
Male
(119)
Middle Aged
(117)
Oncology
(112)
Life Sciences
(104)
Aged
(98)
Adult
(91)
Leukemia, Myeloid, Acute - Drug Therapy
(83)
Acute Myeloid Leukemia
(69)
Leukemia, Myeloid, Acute - Genetics
(65)
Treatment Outcome
(60)
Mutation
(58)
Leukemia
(56)
Prognosis
(53)
Chemotherapy
(46)
Aged, 80 And Over
(45)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(228)
Journal Of Clinical Oncology
(27)
Haematologica
(22)
Blood Advances
(14)
Clinical Lymphoma, Myeloma And Leukemia
(14)
American Journal Of Hematology
(13)
Leukemia Research
(13)
British Journal Of Haematology
(12)
Cancer Research
(12)
Leukemia & Lymphoma
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The beginning of a new therapeutic era in acute myeloid leukemia

Hematidrosis as a manifestation of COVID‐19 containment‐induced stress

Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials

Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells

Secondary acute myeloid leukemia: time to turn the page

Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

Clinical Implications of Inflammation in Acute Myeloid Leukemia

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism

Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey

Follow-up of patients with R/R FLT3-mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial

Dendrogenin A drives LXR to trigger lethal autophagy in cancers

Differential prognostic values of the three AKT isoforms in acute myeloid leukemia

Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study

Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients

Genomic landscape of hyperleukocytic acute myeloid leukemia

The ROS/SUMO Axis Contributes to the Response of Acute Myeloid Leukemia Cells to Chemotherapeutic Drugs

High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia

Antileukemic activity of rapamycin in acute myeloid leukemia

Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia

Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia

Cost comparison of post-remission strategies in younger and older AML patients in France

Suchergebnisse filtern